Skip to main content
Log in

Dihydroergotamine decreases the blood content in the skeletal musculature but etilefrine hydrochloride in the splanchnic region in man

  • Original Contributions
  • Published:
Basic Research in Cardiology Aims and scope Submit manuscript

Summary

Dihydroergotamine (DHE, Dihydergot®) constricts the capacitance vessels of the striated musculature about twice as strong as etilefrine hydrochloride (E, Effortil®) for the same increment in central venous pressure. This and the additive effects of both agents on central venous pressure suggested that E may constrict primarily splanchnic capacitance vessels, a hypothesis, that was tested here by looking at the regional distribution of99Tc-marked erythrocytes in healthy volunteers.

With the subjects supine under a gamma camera the radioactivity was recorded along with central venous pressure, heart rate, and arterial pressure and evaluated for various regions. E was infused twice at a rate of 5 μg/kg per minute before and after the injection of DHE (7.5 μg/kg).

E reduced strongly and selectively the radioactivity in the splanchnic area, not however in skeletal muscle. The reverse held for DHE. Both agents increased the counting rates in the thorax and also central venous pressure, effects which were additive when the two drugs acted together.

E preferentially expels blood from the splanchnic vasculature, but DHE from skeletal muscle. The effects add and redistribute blood in favour of the intrathoracic circulation so that the combination of the two agents could be used to advantage for the treatment of cardiac filling disturbances.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Alexander RS (1954) The influence of constrictor drugs on the distensibility of the splanchnic venous system, analyzed on the basis of an aortic model. Circ Res 2:140–147

    PubMed  Google Scholar 

  2. Berde B, Schild HO (1978) Ergot Alkaloids and related Compounds. Handb exp Pharmacol 49. Springer-Verlag, Berlin Heidelberg New York

    Google Scholar 

  3. Echt M, Lange L (1972) Die Beeinflussung des venösen Gefäßtonus durch Effortil. Münch med Wschr 114:1418–1420

    Google Scholar 

  4. Echt M, Düweling J, Gauer OH, Lange (1974) Effective compliance of the total vascular bed and the intrathoracic compartment derived from changes in central venous pressure induced by volume changes in man. Circ Res 34:61–68

    Google Scholar 

  5. Dehnen-Seipel H, Arndt JO, Bircks W (1978) Die Compliance der intra- und extrathorakalen Gefäßabschnitte des Menschen. In: Schaper W, Gottwik MG (Hrsg): Elektrokardiodiagnostik. Der kardiale Notfall. Verhandlungen der Deutschen Gesellschaft für Kreislaufforschung, 44. Tagung. 161, Darmstadt

  6. Gauer OH, Henry JP, Sieker HO, Edelberg R (1956) Changes in central venous pressure after moderate hemorrhage and transfusion in man. Circ Res 4:79–84

    PubMed  Google Scholar 

  7. Glaser EM, McPherson DR, Prior KM, Charles E (1954) Radiological investigation of the effects of hemorrhage on the lungs, liver and spleen, with special reference to the storage of blood in man. Clin Sci 13:461–473

    PubMed  Google Scholar 

  8. Höck A, Höck A, Vyska K, Freundlieb Ch, Feinendegen LE (1977) A new radiographic method for continuously measuring changes of cardiac volume under exercise. In: Nuklearmedizin (Stand und Zukunft). Schattauer, Stuttgart New York

    Google Scholar 

  9. Inoue H, Inoue K, Arndt JO (1980) Die Interaktion von Dihydroergotamin und Etilefrinhydrochlorid an den Kapazitätsgefäßen der Wade des Menschen. Z Kard 69:280–286

    Google Scholar 

  10. Kobinger W (1965) Über die unterschiedliche Beeinflussung von Widerstand- und Kapazitätsgefäßen durch verschiedene Sympathikomimetika. Arch exp Path Pharmakol 252:103–121

    Google Scholar 

  11. Laube L, Reichelt W, Arndt JO (1977) Vergleichende Untersuchungen über die Venenwirksamkeit des ADH-Abkömmlings Orthinin-8-Vasopressin sowie von Dihydroergotamin am kreislaufgesunden Menschen. Herz/Kreisl 9:295–302

    Google Scholar 

  12. Mellander S (1966) Comparative effects of acetalcholine, butylnorsynephrine (vasculat), noradrenaline and ethyl-adrianol (effortil) on resistance, capacitance, and precapillary sphincter vessels and capillary filtration in cat skeletal muscle. Angiologica 3:77–99

    PubMed  Google Scholar 

  13. Mellander S, Nordenfelt I (1971) Comparative effects of dihydroergotamine and noradrenaline on resistance, exchange and capacitance functions in the peripheral circulation. Clin Sci 39:183–201

    Google Scholar 

  14. Mostbeck A, Partsch H, Peschl L (1977) Änderungen der Blutvolumenverteilung im Ganzkörper unter physikalischen und pharmakologischen Maßnahmen. VASA 6:137–142

    PubMed  Google Scholar 

  15. Shepherd IT (1980) Reflex control of the venous system in man. In: Advances in physiological sciences. Vol 9, Kováck AGB, Sandor P, Kollai M (eds). Pergamon Press

  16. Smith TD, Richards P (1976) A simple kit for the preparation of99mTc-labelled red blood cells. J nucl Med 17:126

    PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Additional information

The support of the “Deutsche Forschungsgemeinschaft” through the “Sonderforschungsbereich 30 Kardiologie Düsseldorf” is gratefully acknowledged.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Arndt, J.O., Höck, A. & Inoue, K. Dihydroergotamine decreases the blood content in the skeletal musculature but etilefrine hydrochloride in the splanchnic region in man. Basic Res Cardiol 79, 244–252 (1984). https://doi.org/10.1007/BF01908311

Download citation

  • Received:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01908311

Key words

Navigation